STA, 10 February 2022 - The Slovenian start-up Mediately has raised EUR 7.2 million in Series A funding to expand its mobile app for doctors to the largest markets in Europe. The app facilitates access to medical knowledge for doctors by simplifying an adapting complex and extensive medical content.
Mediately has raised the funds to expand from the eight markets in Europe in which it is currently present. The round is led by Piton Capital, and joined by VentureFriends and the current investors Silicon Gardens, LAUNCHub Ventures, and smaller angel investors.
"Organic growth, which is mostly spread by word of mouth, an impressive number of doctors who use the app every day, and outstanding user reviews show that the team has created an app with really high value for doctors," said Piton Capital investor Mira Mihaylova.
Mediately noted that, in addition to monitoring innovation in medicine when working with patients, doctors must also be aware of the relevant regulations, restrictions in prescribing medications, and follow treatment guidelines and diagnostic measures.
Doctors often operate with insufficient information for making the best treatment decisions, as software in hospitals and other healthcare facilities is mostly intended for administration, with less emphasis on informing doctors, the company said.
It added that other medical mobile apps usually do not take into account local specifics, so doctors are often left to their own devices and obtain information from various sources, which is time-consuming.
"Doctors should have access to the best support for decision-making ... and this is the only way they can take the best care of their patients' health, and we want to help them with that," said Mediately executive director Blaž Triglav.
The app, initially available only to Slovenian doctors, is today used by 80-90% of Slovenian doctors on a daily basis, the company said, adding that the positive response at home had led to the successful expansion to several European markets.
VentureFriends founding partner Apostolos Apostolakis said that "Mediately has a high potential to become a leading platform of medical knowledge for European doctors", adding that the app was also a strong communication channel for pharmaceutical companies.